Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
- Bernard Chevalier
- , Yoshinobu Onuma
- , Ad J van Boven
- , Jan J Piek
- , Manel Sabaté
- , Steffen Helqvist
- , Andreas Baumbach
- , Pieter C Smits
- , Ravindra Kumar
- , Luc Wasungu
- , Patrick W Serruys
55
Citationer
(Scopus)